← Back to company shares
AP
Apex Ventures
APVE · BiotechnologyApplied biotechnology research aimed at treating chronic and rare conditions. Backed by Apex Ventures's operating track record in the biotechnology space.
Price / Share
$85.8
Shares Sold
296,750 / 750,000
Shares Remaining
453,250
40% subscribed
Log in to purchase shares